Article Details

2022 forecast: Biopharma M&A lags in 2021. Will drugmakers still look for bolt-on deals or ...

Retrieved on: 2021-12-22 15:03:52

Tags for this article:

Click the tags to see associated articles and topics

2022 forecast: Biopharma M&A lags in 2021. Will drugmakers still look for bolt-on deals or .... View article details on hiswai:

Excerpt

... merger and acquisition activity by drugmakers went largely quiet in 2021. But after all the slim-downs, biopharma M&A might finally see a rebound.

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up